story of the week
Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma
N. Engl. J. Med 2023 Jan 19;388(3)228-239, L Goyal, F Meric-Bernstam, A Hollebecque, JW Valle, C Morizane, TB Karasic, TA Abrams, J Furuse, RK Kelley, PA Cassier, HJ Klümpen, HM Chang, LT Chen, J Tabernero, DY Oh, A Mahipal, M Moehler, EP Mitchell, Y Komatsu, K Masuda, D Ahn, RS Epstein, AB Halim, Y Fu, T Salimi, V Wacheck, Y He, M Liu, KA Benhadji, JA BridgewaterFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.